Note: Ingredients listed on restricted chemical lists
EC/CAS
119-36-8
Name of the chemical
Methyl salicylate
Concentration
N/A
EC/CAS
89-78-1
Name of the chemical
Menthol; dl-menthol; l-menthol; d-menthol (40)
Concentration
N/A
EC/CAS
128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
N/A
General Information
Revision date
2022-03-09
Product name
IODEX HERBAL GEL (MFC70131)
Product Synonyms
PROJECT IODEX HERBAL GEL * MFC70131 (MFR/EXT/024) * KUNDURU NIRYASA
1.2.2. Uses advised against
No other uses are advised
supplier name
GlaxoSmithKline UK
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Danger
Section 2
SECTION 2: Hazards identification
result in GHS classification: 2.1 GHS classification of substance or mixture, and national or regional information
Physical hazards
Not classified.
Health hazards
Serious eye damage/eye irritation Category 1 Sensitization, skin Category 1
Environmental hazards
Hazardous to the aquatic environment, Category 3
Signal word
Danger
Hazard statements
May cause an allergic skin reaction. Causes serious eye damage. Harmful to aquatic life with long lasting effects.
Prevention
Avoid breathing mist/vapours. Contaminated work clothing should not be allowed out of the workplace. Avoid release to the environment. Wear eye protection/face protection. Wear protective gloves.
Response
IF ON SKIN Wash with plenty of soap and water. IF IN EYES Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTRE or doctor/physician. Specific treatment (see instruction on this label). If skin irritation or rash occurs: Get medical advice/attention. Wash contaminated clothing before reuse.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. 2.3 Other hazards which do not Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health result in GHS classification hazards.
Additional information
7 % of the mixture consists of component(s) of unknown acute oral toxicity. 10.85 % of the mixture consists of component(s) of unknown acute dermal toxicity. 5.5 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 7 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 5.5 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
